News and events

Spotlight news

March 16, 2026

Our 2024/2025 ESG report marks a year of progress

We are pleased to announce the release of our ESG report for 2024/2025, which describes our collective progress across environmental sustainability, social responsibility and ethical governance.

All
  • All
  • News
  • Articles
  • Events

Medical Affairs Communications Team of the Year: Oxford PharmaGenesis colleagues win prestigious 2023 PharmaTimes award

Congratulations to Oxford PharmaGenesis colleagues who were named Medical Affairs Communications Team of the Year at the PharmaTimes gala dinner and awards ceremony on Thursday 16 November!

Continue reading

MS Brain Health highly commended for PRIME Award for Sustained Excellence in recognition of the impact of its policy recommendations

Oxford PharmaGenesis, Oxford Health Policy Forum and MS Australia are celebrating the shortlisting of MS Brain Health for a PRIME Award for Sustained Excellence, and are incredibly proud to have been highly commended at the award ceremony. The awards took place in Sydney, Australia, on Thursday 9 November 2023. The PRIME Awards recognize and celebrate…

Continue reading

Oxford PharmaGenesis sponsors global HIFA-WHO consultation to promote reliable healthcare information

Oxford PharmaGenesis is proud to sponsor a global consultation, run by Healthcare Information For All (HIFA) in partnership with the World Health Organization (WHO), to accelerate progress towards universal access to reliable healthcare information. Every day, tens of thousands of children and adults die needlessly for want of simple, low-cost interventions, which are often locally…

Continue reading

Find us at ISPOR Europe 2023

HEOR and market access are evolving, with big changes in HTA around the corner, acceleration in the use of RWE and increased reactions to cost-containment measures. We are contributing to conversations about how these changes affect value demonstration strategies. At Oxford PharmaGenesis, we are experts in advising on payer strategy, developing payer evidence and supporting payer evaluation. We understand differences in payer evidence needs, and we know how to create compelling value stories for our clients that achieve powerful results.

Continue reading
Open access

Benchmarking open access in publications with authors affiliated to pharma companies and universities

Many scientific and medical publications lie behind a paywall. New medical research is increasingly being published as ‘open access’, which makes articles freely available to anyone. This provides major benefits because it gives researchers and members of the public equal access to medical knowledge. It also improves research transparency, which helps to foster public trust.

Continue reading

ISMPP Academy report: Oxford PharmaGenesis teaches how to elevate publications through enhanced impact and demystifies RWE and HEOR

More than 150 medical publications professionals gathered in Philadelphia on 28–29 September 2023 for the inaugural ISMPP Academy. Oxford PharmaGenesis was a key event sponsor and we were delighted to give two valuable presentations to help attendees to explore new frontiers in publications. In line with the ISMPP Academy theme ‘PREP! Practical Resources to Elevate…

Continue reading